HENDERSON MICHAEL THOMAS Insider Trades

Insider Trading History

Track insider trading activity for HENDERSON MICHAEL THOMAS. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Spyre Therapeutics
Spyre Therapeutics SYRE
Director
Holding Value $630k 8,026 shares
Last Trade
May 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$582k 8,026 shares
$72.51
$78.48
Apogee Therapeutics
Apogee Therapeutics APGE
Chief Executive Officer
Holding Value $101M 1,115,987 shares
Last Trade
May 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$111k 1,341 shares
$82.58
$90.90
Apogee Therapeutics
Apogee Therapeutics APGE
Chief Executive Officer
Holding Value $102M 1,117,328 shares
Last Trade
May 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.53M 18,659 shares
$82.05
$90.90
Spyre Therapeutics
Spyre Therapeutics SYRE
Director
Holding Value $8.47M 107,875 shares
Last Trade
May 08, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.86M 24,814 shares
$74.76
$78.48
Spyre Therapeutics
Spyre Therapeutics SYRE
Director
Holding Value $10.4M 132,689 shares
Last Trade
May 08, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.47M 33,513 shares
$73.72
$78.48
Spyre Therapeutics
Spyre Therapeutics SYRE
Director
Holding Value $13M 166,202 shares
Last Trade
May 08, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$174k 2,404 shares
$72.57
$78.48
Spyre Therapeutics
Spyre Therapeutics SYRE
Director
Holding Value $6.95M 88,606 shares
Last Trade
May 08, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.45M 19,269 shares
$75.35
$78.48
Apogee Therapeutics
Apogee Therapeutics APGE
Chief Executive Officer
Holding Value $35.2M 387,012 shares
Last Trade
Apr 16, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$267k 3,000 shares
$88.95
$90.90
Apogee Therapeutics
Apogee Therapeutics APGE
Chief Executive Officer
Holding Value $103M 1,135,987 shares
Last Trade
Apr 16, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$267k 3,000 shares
$88.95
$90.90
Apogee Therapeutics
Apogee Therapeutics APGE
Chief Executive Officer
Holding Value $103M 1,133,187 shares
Last Trade
Apr 08, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$167k 2,000 shares
$83.26
$90.90
Apogee Therapeutics
Apogee Therapeutics APGE
Chief Executive Officer
Holding Value $103M 1,132,987 shares
Last Trade
Apr 08, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$17k 200 shares
$85.00
$90.90
Apogee Therapeutics
Apogee Therapeutics APGE
Chief Executive Officer
Holding Value $103M 1,135,187 shares
Last Trade
Apr 08, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.47M 17,800 shares
$82.48
$90.90
Apogee Therapeutics
Apogee Therapeutics APGE
Chief Executive Officer
Holding Value $105M 1,152,987 shares
Last Trade
Mar 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$259k 3,418 shares
$75.86
$90.90
Apogee Therapeutics
Apogee Therapeutics APGE
Chief Executive Officer
Holding Value $106M 1,164,624 shares
Last Trade
Mar 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$621k 8,363 shares
$74.29
$90.90
Apogee Therapeutics
Apogee Therapeutics APGE
Chief Executive Officer
Holding Value $105M 1,156,405 shares
Last Trade
Mar 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$615k 8,219 shares
$74.83
$90.90
Apogee Therapeutics
Apogee Therapeutics APGE
Chief Executive Officer
Holding Value $107M 1,173,942 shares
Last Trade
Feb 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$481k 7,551 shares
$63.73
$90.90
Apogee Therapeutics
Apogee Therapeutics APGE
Chief Executive Officer
Holding Value $107M 1,172,987 shares
Last Trade
Feb 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$62.1k 955 shares
$64.99
$90.90
Apogee Therapeutics
Apogee Therapeutics APGE
Chief Executive Officer
Holding Value $107M 1,181,493 shares
Last Trade
Feb 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$724k 11,494 shares
$62.96
$90.90
Spyre Therapeutics
Spyre Therapeutics SYRE
Director
Holding Value $13.2M 168,606 shares
Last Trade
Jan 21, 2026 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$2.15M 63,227 shares
$33.99
$78.48
Apogee Therapeutics
Apogee Therapeutics APGE
Chief Executive Officer
Holding Value $108M 1,193,457 shares
Last Trade
Jan 14, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$448k 5,386 shares
$83.16
$90.90

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up